Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The WiSE®-UP Study (The WiSE System Utilization & Performance Study)

NCT: NCT07098858 · RECRUITING

NCT IDNCT07098858
StatusRECRUITING
Start Date2025-11-03
Completion2032-09-30
SponsorEBR Systems, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

Observe to understand product performance, including patient safety, clinical outcomes, and CRT response information associated with the use of the market-released WiSE System

Frequently Asked Questions

What is The WiSE®-UP Study (The WiSE System Utilization & Performance Study)?

The WiSE®-UP Study (The WiSE System Utilization & Performance Study) is a clinical trial registered under NCT07098858. Current status: RECRUITING.

What is the status of NCT07098858?

The current status of NCT07098858 (The WiSE®-UP Study (The WiSE System Utilization & Performance Study)) is: RECRUITING.

When did The WiSE®-UP Study (The WiSE System Utilization & Performance Study) start?

The WiSE®-UP Study (The WiSE System Utilization & Performance Study) started on 2025-11-03.

Related Devices

PMA P240028Leadless Cardiac Resynchronization Therapy (CRT)EBR Systems, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑